Copyright
©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 100413
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.100413
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.100413
Characteristics | Patients |
Age (years); median (minimum-maximum) | 53 (23-69) |
Male sex | 13 (92.8) |
Vaccination for yellow fever more than 10 days ago | 3 (21.4) |
Comorbidities | |
Smoking | 3 (21.4) |
Hypertension | 2 (21.4) |
Immunosuppressed (previous renal transplant) | 1 (7.1) |
Diabetes | 0 |
Time from symptoms onset to admission (days), mean (minimum-maximum) | 4-7 (1-8) |
Signs and symptoms at hospital admission | |
Myalgia | 12 (85.7) |
Fever | 11 (78.6) |
Jaundice | 11 (78.6) |
Vomiting | 7 (50) |
Headache | 6 (42.9) |
Abdominal pain | 4 (28.6) |
Diarrhea | 2 (14.3) |
Distance between exposure location and hospital (km), mean (minimum-maximum) | 1487 (30-291) |
Rural workers | 6 (42.6) |
- Citation: Athanasio BDS, Andrade AMF, Costa VV, Castro JF, Garcia SLM, Teixeira MM, Souza DDG, Vidigal PVT, Lima CX. King's College criteria and the Clichy-Villejuif criteria require adjustments for assessing acute liver failure due to yellow fever. World J Transplant 2025; 15(1): 100413
- URL: https://www.wjgnet.com/2220-3230/full/v15/i1/100413.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i1.100413